Interest Expense of Barinthus Biotherapeutics plc. from 30 Sep 2020 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Barinthus Biotherapeutics plc. quarterly and annual Interest Expense in USD history and change rate from 30 Sep 2020 to 31 Mar 2024.
Barinthus Biotherapeutics plc. Interest Expense for the quarter ending 31 Mar 2024 was $12,000.
Barinthus Biotherapeutics plc. annual Interest Expense for 2023 was $28,000, a 47% increase from 2022.
Barinthus Biotherapeutics plc. annual Interest Expense for 2022 was $19,000, a 99% decline from 2021.
Barinthus Biotherapeutics plc. annual Interest Expense for 2021 was $2,668,000, a 26% decline from 2020.
Source SEC data: View on sec.gov

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Change (%)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Change (%)

Barinthus Biotherapeutics plc. Quarterly Interest Expense (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$12,000	+$12,000		01 Jan 2024	31 Mar 2024	10-Q	13 May 2024	2024	Q1
Q1 2023	$0	-$74,000	-100%	01 Jan 2023	31 Mar 2023	10-Q	13 May 2024	2024	Q1
Q1 2022	$74,000	-$2,576,000	-97%	01 Jan 2022	31 Mar 2022	10-Q	12 May 2023	2023	Q1
Q1 2021	$2,650,000			01 Jan 2021	31 Mar 2021	10-Q	11 May 2022	2022	Q1
Q3 2020	$969,000			01 Jul 2020	30 Sep 2020	10-Q	12 Nov 2021	2021	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$28,000	+$9,000	+47%	01 Jan 2023	31 Dec 2023	10-K	20 Mar 2024	2023	FY
2022	$19,000	-$2,649,000	-99%	01 Jan 2022	31 Dec 2022	10-K	20 Mar 2024	2023	FY
2021	$2,668,000	-$932,000	-26%	01 Jan 2021	31 Dec 2021	10-K	24 Mar 2023	2022	FY
2020	$3,600,000			01 Jan 2020	31 Dec 2020	10-K	25 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.